Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $795.56 | 36 | 95.4% |
| Education | $38.78 | 2 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $130.84 | 6 | $0 (2023) |
| Jazz Pharmaceuticals Inc. | $115.00 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $63.75 | 3 | $0 (2021) |
| Lundbeck LLC | $51.62 | 3 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.17 | 2 | $0 (2021) |
| GENZYME CORPORATION | $40.22 | 2 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $38.78 | 2 | $0 (2021) |
| Horizon Therapeutics plc | $34.48 | 2 | $0 (2023) |
| Daiichi Sankyo Inc. | $31.84 | 2 | $0 (2022) |
| Amgen Inc. | $25.37 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.47 | 2 | Amgen Inc. ($25.37) |
| 2023 | $81.26 | 3 | Janssen Pharmaceuticals, Inc ($42.13) |
| 2022 | $48.35 | 3 | AKEBIA THERAPEUTICS INC ($22.64) |
| 2021 | $232.95 | 11 | Takeda Pharmaceuticals U.S.A., Inc. ($50.17) |
| 2020 | $203.58 | 12 | Janssen Pharmaceuticals, Inc ($65.04) |
| 2019 | $14.11 | 1 | Lundbeck LLC ($14.11) |
| 2018 | $72.80 | 4 | GENZYME CORPORATION ($22.13) |
| 2017 | $130.82 | 2 | Jazz Pharmaceuticals Inc. ($115.00) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Cardio-renal | ||||||
| 07/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/31/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Genetic Disease | ||||||
| 08/25/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: KRYSTEXXA | ||||||
| 02/23/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $42.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/20/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.42 | General |
| Category: Cardiovascular | ||||||
| 03/10/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Nephrology | ||||||
| 01/11/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/03/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Neurology | ||||||
| 07/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.61 | General |
| Category: NEPHROLOGY | ||||||
| 06/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/03/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/01/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiovascular | ||||||
| 02/12/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Kidney Stones | ||||||
| 02/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/03/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $17.17 | General |
| Category: NEPHROLOGY | ||||||
| 12/07/2020 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Genetic Disease | ||||||
| 11/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/11/2020 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/02/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2020 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 281 | 985 | $357,715 | $76,725 |
| 2022 | 8 | 553 | 1,100 | $475,845 | $78,634 |
| 2021 | 7 | 484 | 869 | $343,036 | $74,150 |
| 2020 | 11 | 745 | 1,192 | $363,084 | $93,092 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 124 | 471 | $212,321 | $43,592 | 20.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 335 | $83,007 | $21,007 | 25.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 64 | 64 | $35,926 | $5,584 | 15.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 94 | $13,941 | $3,680 | 26.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $12,521 | $2,862 | 22.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 207 | 520 | $245,111 | $41,457 | 16.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 98 | 262 | $86,118 | $14,177 | 16.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 135 | 138 | $77,495 | $11,274 | 14.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 20 | $15,217 | $3,071 | 20.2% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 27 | 35 | $17,497 | $2,665 | 15.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 28 | 86 | $14,586 | $2,562 | 17.6% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $12,615 | $2,316 | 18.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 21 | 21 | $7,206 | $1,111 | 15.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 176 | 480 | $174,458 | $39,957 | 22.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 115 | 120 | $47,223 | $10,082 | 21.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 58 | 60 | $39,025 | $8,276 | 21.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 46 | 111 | $34,486 | $6,339 | 18.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 31 | $23,694 | $4,877 | 20.6% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 26 | 35 | $16,332 | $2,779 | 17.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 32 | 32 | $7,819 | $1,839 | 23.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 169 | 394 | $131,323 | $33,635 | 25.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 136 | 318 | $68,807 | $18,403 | 26.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 118 | 121 | $41,900 | $10,642 | 25.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 59 | 59 | $36,386 | $8,337 | 22.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 44 | 44 | $29,869 | $7,253 | 24.3% |
About Dr. Mukesh Thawani, M.D
Dr. Mukesh Thawani, M.D is a Internal Medicine healthcare provider based in Roseburg, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174716427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mukesh Thawani, M.D has received a total of $834.34 in payments from pharmaceutical and medical device companies, with $50.47 received in 2024. These payments were reported across 38 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($795.56).
As a Medicare-enrolled provider, Thawani has provided services to 2,063 Medicare beneficiaries, totaling 4,146 services with total Medicare billing of $322,601. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Internal Medicine
- Location Roseburg, OR
- Active Since 08/21/2007
- Last Updated 09/26/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174716427
Products in Payments
- XARELTO (Drug) $130.84
- Xyrem (Drug) $115.00
- LOKELMA (Drug) $63.75
- KRYSTEXXA (Biological) $59.85
- NORTHERA (Drug) $51.62
- RAYALDEE (Drug) $38.78
- INJECTAFER (Drug) $31.84
- GATTEX (Drug) $25.65
- Kerendia (Drug) $25.10
- TRINTELLIX (Drug) $24.52
- BENLYSTA (Biological) $23.46
- Auryxia (Drug) $22.64
- FABRY-DISEASE (Drug) $22.13
- Thiola (Drug) $20.00
- JYNARQUE (Drug) $18.24
- OXLUMO (Drug) $18.24
- FABRAZYME (Biological) $18.09
- Vascepa (Drug) $17.85
- Velphoro (Drug) $17.68
- Dayvigo (Drug) $17.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Roseburg
William Townsend, Md, MD
Internal Medicine — Payments: $3,059
Dr. Mohamed Abdel Khalek, M.d, M.D
Internal Medicine — Payments: $1,602
Lorrie Oksenholt, Do, DO
Internal Medicine — Payments: $1,576
Joel Lee, Md, MD
Internal Medicine — Payments: $1,275
Doru Totoian, Md, MD
Internal Medicine — Payments: $1,266
Dr. Hennie Abrio, Md, MD
Internal Medicine — Payments: $970.03